Latest Pharma-News

TWILIGHT trial showed that Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding compared to dual antiplatelet therapy (DAPT) in patients with non-ST...

Novartis Phase III PARAGON-HF study: Substantial reductions in heart failure with preserved ejection fraction with Entresto

Cardiff University’s scientist awarded the funding of £373k to diagnose pancreatic cancer at an earlier stage

SurVaxM: A novel anti-cancer immunotherapy for the treatment of glioblastoma brain cancers

Initiation Of First Large-Scale Registry :To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors

Single, subanesthetic-dose of ketamine infusion relatively free of side effects for patients with treatment-resistant depression

New Novartis medicine Adakveo® (crizanlizumab) approved by FDA for the treatment of individuals living with sickle cell disease

BMS and Pfizer to start a new randamized controlled trial accessing the impact of atrial fibrillation screening on health outcomes in older individuals

FDA approves Talicia To Treat bacterial infection Linked To Stomach Cancer

Zydus Cadila gets tentative approval from USFDA for Apremilast tablets for the treatment of psoriatic arthritis

New antibacterial drug approved by FDA to treat complicated urinary tract infections for antimicrobial resistance